What Happens When You Stop Taking Obesity Medication and How to Stay on Track

Stopping an obesity medication is not always a choice. Sometimes it is a necessity, and for clinical pharmacist Sherrie Singh-Bryan, Pharm.D., of Winn Army Community Hospital and the Obesity Medicine Association, preparing patients for that reality is just as important as prescribing the medication in the first place.

Stopping Is Not Failing

Most patients assume the main reason someone stops an obesity medication is cost. Singh-Bryan sees a broader picture. Patients preparing for surgery requiring general anesthesia must stop their GLP-1 medications ahead of the procedure. A delayed adverse reaction may make continuing the medication unsafe. A manufacturer shortage can make it simply unavailable, as happened during the global GLP-1 back order that lasted several months and affected patients worldwide.

Whatever the reason, the response she coaches her patients toward is the same: Do not jump down the rabbit hole.

That is her phrase for the spiral that can happen when a medication is suddenly unavailable. The fear of weight regain sets in. The sense of losing control follows. And instead of problem-solving, patients freeze. Her approach is to get ahead of that moment by reframing the medication’s role from the very beginning of treatment. The medication is a tool, not the driver. If it has to stop, the other pillars of treatment — nutrition, movement, mindset — do not stop with it.

She encourages patients to call their doctor calmly, ask about alternatives, check with the insurance company and explore what options exist. Because obesity is now treated as a chronic disease, patients have ongoing relationships with their providers who can help navigate those transitions rather than leaving patients to figure it out alone.

The Cost Barrier Is Real and Growing

Last year, manufacturer coupons made GLP-1 medications significantly more accessible. That landscape has shifted. More insurance plans are removing weight loss medications from their formularies. Coupons are less readily available. And because GLP-1 medications are newer, no generic versions exist yet.

But Singh-Bryan points out that not all obesity medications are new. Older oral medications like topiramate, the active ingredient in Qsymia, have been available in generic form for years and carry a fraction of the cost. Having an open conversation with a trusted provider about what is actually affordable and available can open doors that patients do not know exist.

She also addressed the topic of compounded medications, which have become increasingly common as patients search for more affordable alternatives. She acknowledged that some compounding pharmacies working directly with physicians may offer a more reliable product, but warned that medications received in the mail from unknown sources carry real safety concerns. Her recommendation is clear: Do not navigate this alone.

The Last Question That Almost Got Lost

In the final question of the interview, Singh-Bryan was asked to address the stigma that still surrounds taking medication for obesity, with some patients feeling it is the easy way out.

She draws a direct parallel to medication-assisted smoking cessation. Research has consistently shown that people trying to quit smoking have higher rates of success when medication is part of the plan. The same is true for managing addictive or habitual behaviors of all kinds. Obesity, she explained, often develops through coping mechanisms, responses to trauma or deeply ingrained habits that took years to form. Having a medication that assists in changing those patterns is not a shortcut. It is a clinically supported advantage.

By the time most patients reach an obesity specialist, they have already tried multiple approaches on their own, diet changes, exercise programs, and everything in between. Coming to a provider is not a sign of failure. It is a sign of someone who is serious about increasing their chance of success.

She also challenged the idea that rapid weight loss is the goal. Losing weight quickly typically means regaining it just as quickly. She would rather a patient lose 4 pounds over four to five weeks and keep it off than drop 12 pounds and regain 4 the following month. Patience, she said, is not a passive virtue in this context. It is a clinical strategy.

Her closing message: Medications can always be adjusted, changed or discontinued if they are not the right fit. What matters is staying open, staying informed and staying in the driver’s seat of your own health journey.